Cargando…

An Accelerated Failure Time Cure Model with Shifted Gamma Frailty and Its Application to Epidemiological Research

Survival analysis is a set of methods for statistical inference concerning the time until the occurrence of an event. One of the main objectives of survival analysis is to evaluate the effects of different covariates on event time. Although the proportional hazards model is widely used in survival a...

Descripción completa

Detalles Bibliográficos
Autores principales: Aida, Haro, Hayashi, Kenichi, Takeuchi, Ayano, Sugiyama, Daisuke, Okamura, Tomonori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332026/
https://www.ncbi.nlm.nih.gov/pubmed/35893205
http://dx.doi.org/10.3390/healthcare10081383
_version_ 1784758547868811264
author Aida, Haro
Hayashi, Kenichi
Takeuchi, Ayano
Sugiyama, Daisuke
Okamura, Tomonori
author_facet Aida, Haro
Hayashi, Kenichi
Takeuchi, Ayano
Sugiyama, Daisuke
Okamura, Tomonori
author_sort Aida, Haro
collection PubMed
description Survival analysis is a set of methods for statistical inference concerning the time until the occurrence of an event. One of the main objectives of survival analysis is to evaluate the effects of different covariates on event time. Although the proportional hazards model is widely used in survival analysis, it assumes that the ratio of the hazard functions is constant over time. This assumption is likely to be violated in practice, leading to erroneous inferences and inappropriate conclusions. The accelerated failure time model is an alternative to the proportional hazards model that does not require such a strong assumption. Moreover, it is sometimes plausible to consider the existence of cured patients or long-term survivors. The survival regression models in such contexts are referred to as cure models. In this study, we consider the accelerated failure time cure model with frailty for uncured patients. Frailty is a latent random variable representing patients’ characteristics that cannot be described by observed covariates. This enables us to flexibly account for individual heterogeneities. Our proposed model assumes a shifted gamma distribution for frailty to represent uncured patients’ heterogeneities. We construct an estimation algorithm for the proposed model, and evaluate its performance via numerical simulations. Furthermore, as an application of the proposed model, we use a real dataset, Specific Health Checkups, concerning the onset of hypertension. Results from a model comparison suggest that the proposed model is superior to existing alternatives.
format Online
Article
Text
id pubmed-9332026
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93320262022-07-29 An Accelerated Failure Time Cure Model with Shifted Gamma Frailty and Its Application to Epidemiological Research Aida, Haro Hayashi, Kenichi Takeuchi, Ayano Sugiyama, Daisuke Okamura, Tomonori Healthcare (Basel) Article Survival analysis is a set of methods for statistical inference concerning the time until the occurrence of an event. One of the main objectives of survival analysis is to evaluate the effects of different covariates on event time. Although the proportional hazards model is widely used in survival analysis, it assumes that the ratio of the hazard functions is constant over time. This assumption is likely to be violated in practice, leading to erroneous inferences and inappropriate conclusions. The accelerated failure time model is an alternative to the proportional hazards model that does not require such a strong assumption. Moreover, it is sometimes plausible to consider the existence of cured patients or long-term survivors. The survival regression models in such contexts are referred to as cure models. In this study, we consider the accelerated failure time cure model with frailty for uncured patients. Frailty is a latent random variable representing patients’ characteristics that cannot be described by observed covariates. This enables us to flexibly account for individual heterogeneities. Our proposed model assumes a shifted gamma distribution for frailty to represent uncured patients’ heterogeneities. We construct an estimation algorithm for the proposed model, and evaluate its performance via numerical simulations. Furthermore, as an application of the proposed model, we use a real dataset, Specific Health Checkups, concerning the onset of hypertension. Results from a model comparison suggest that the proposed model is superior to existing alternatives. MDPI 2022-07-25 /pmc/articles/PMC9332026/ /pubmed/35893205 http://dx.doi.org/10.3390/healthcare10081383 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Aida, Haro
Hayashi, Kenichi
Takeuchi, Ayano
Sugiyama, Daisuke
Okamura, Tomonori
An Accelerated Failure Time Cure Model with Shifted Gamma Frailty and Its Application to Epidemiological Research
title An Accelerated Failure Time Cure Model with Shifted Gamma Frailty and Its Application to Epidemiological Research
title_full An Accelerated Failure Time Cure Model with Shifted Gamma Frailty and Its Application to Epidemiological Research
title_fullStr An Accelerated Failure Time Cure Model with Shifted Gamma Frailty and Its Application to Epidemiological Research
title_full_unstemmed An Accelerated Failure Time Cure Model with Shifted Gamma Frailty and Its Application to Epidemiological Research
title_short An Accelerated Failure Time Cure Model with Shifted Gamma Frailty and Its Application to Epidemiological Research
title_sort accelerated failure time cure model with shifted gamma frailty and its application to epidemiological research
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332026/
https://www.ncbi.nlm.nih.gov/pubmed/35893205
http://dx.doi.org/10.3390/healthcare10081383
work_keys_str_mv AT aidaharo anacceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch
AT hayashikenichi anacceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch
AT takeuchiayano anacceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch
AT sugiyamadaisuke anacceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch
AT okamuratomonori anacceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch
AT aidaharo acceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch
AT hayashikenichi acceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch
AT takeuchiayano acceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch
AT sugiyamadaisuke acceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch
AT okamuratomonori acceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch